• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (33)

    Publication numberPublication dateAssigneeTitle
    EP-1528102-A3October 26, 2005Rockefeller UniversityClonage et production par recombinaison des enzymes du venin de polystinae, telles que la phospholipase et l'hyaluronidase, et therapies immunologiques bases dessus
    US-2003129182-A1July 10, 2003Karageozian Hampar L., Karageozian Vicken H., Kenney Maria Cristina, Gutierrez Flores Jose Luis, Carpio Aragon Gabriel Arturo, Nesburn Anthony B.Hyaluronidase preparation for ophtalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eye
    US-2003175259-A1September 18, 2003Hamper Karageozian, Park John Y., Vicken Karageozian, Phillip Baker, Anthony NesburnUse of corneal hardening agents in enzymeorthokeratology
    US-2004175393-A1September 09, 2004The Rockefeller UniversityCloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and imunological therapies based thereon
    US-2005069531-A1March 31, 2005Hampar Karageozian, Vicken Karageozian, Kenney Maria C., Flores Jose L.G., Carpio Aragon Gabriel Arturo, Nesburn Anthony B.Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
    US-2005137112-A1June 23, 2005Estell David A., Harding Fiona A.Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
    US-2005164257-A1July 28, 2005Estell David A., Harding Fiona A.Proteins producing an altered immunogenic response and methods of making and using the same
    US-2006024764-A1February 02, 2006Estell David A, Harding Fiona AProteins producing an altered immunogenic response and methods of making the same
    US-2006034822-A1February 16, 2006Karageozian Hampar L, Karageozian Vicken H, Kenney Maria C, Gutierrez Flores Jose L, Carpio Aragon Gabriel A, Nesburn Anthony BHyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eye
    US-2007122450-A1May 31, 2007Alberto Osio SanchoTreatment of ophthalmic conditions
    US-2010129831-A1May 27, 2010Sarah BrennerMethods for diagnosing hypersensitivity reactions
    US-6372471-B1April 16, 2002The Rockefeller UniversityCloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
    US-6537545-B1March 25, 2003Ista Pharmaceuticals, Inc.Use of corneal hardening agents in enzymeorthokeratology
    US-6551590-B2April 22, 2003Ista Pharmaceuticals, Inc.Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vireous body of the eye
    US-6596525-B1July 22, 2003Genencor International, Inc.Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
    US-6610292-B2August 26, 2003Ista Pharmaceuticals, Inc.Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
    US-6652851-B1November 25, 2003The Rockefeller UniversityCloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
    US-6773695-B2August 10, 2004Mannkind CorporationModulation of allergic response
    US-6835550-B1December 28, 2004Genencor International, Inc.Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
    US-6838269-B1January 04, 2005Genencor International, Inc.Proteins producing an altered immunogenic response and methods of making and using the same
    US-6863886-B2March 08, 2005Advanced Corneal SystemsUse of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
    US-7060265-B2June 13, 2006The Rockefeller UniversityCloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
    US-8475831-B2July 02, 2013Osio CorporationTreatment of ophthalmic conditions
    US-8679521-B2March 25, 2014Osio CorporationTreatment of ophthalmic conditions
    US-8802836-B2August 12, 2014Pls-Design GmbhCloning and recombinant productions of Vespula venom protease and methods of use thereof
    US-8877228-B2November 04, 2014Osio CorporationTreatment of ophthalmic conditions
    US-9086580-B2July 21, 2015Osio CorporationContact lens use in the treatment of an ophthalmologic condition
    US-9241980-B2January 26, 2016Osio CorporationTreatment of ophthalmic conditions
    US-9566317-B2February 14, 2017Osio CorporationTreatment of ophthalmic conditions
    WO-0018896-A1April 06, 2000The Rockefeller UniversityCloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
    WO-02070665-A2September 12, 2002The Rockefeller University, Alk Abello A/SRecombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
    WO-2010099956-A1September 10, 2010Pls-Design GmbhCloning and recombinant production of vespula venom protease and methods of use thereof